Apoptosis-induction is a novel therapeutic strategy for gastrointestinal and liver cancers

Fei Wang, Haizhong Wang, Xiaotian Sun

  • 1Department of Medicine, Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. xiaotian-sun@hotmail.com.

Current Gene Therapy
|December 25, 2014
PubMed

Insights

This review explores apoptosis, a programmed cell death, as a promising cancer therapy. It summarizes advancements in apoptosis-inducing strategies for gastrointestinal and liver cancers, highlighting their potential to overcome drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Gastrointestinal and liver cancers are prevalent globally.
  • Current treatments face challenges like drug resistance and side effects.
  • Apoptosis, or programmed cell death, is crucial for development and homeostasis.

Purpose of the Study:

  • To provide an overview of the apoptosis system in multicellular organisms.
  • To summarize recent advances in apoptosis-inducing therapeutic strategies.
  • To focus on the application of these strategies for gastrointestinal and liver cancers.

Main Methods:

  • Literature review of apoptosis mechanisms.
  • Analysis of recent studies on apoptosis-inducing cancer therapies.
  • Synthesis of information on therapeutic strategies for gastrointestinal and liver cancers.

Main Results:

  • Apoptosis is a key mechanism for eliminating unwanted cells.
  • Apoptosis-inducing therapy shows promise as a safe and effective anti-cancer approach.
  • Significant progress has been made in developing apoptosis-based treatments.

Conclusions:

  • Apoptosis-inducing therapy represents a vital area for future cancer treatment.
  • This strategy offers a potential solution to overcome limitations of current therapies.
  • Further research into apoptosis modulation holds great promise for treating gastrointestinal and liver cancers.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
17.3K